These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28544873)

  • 21. A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.
    Izadpanah E; Riahi S; Abbasi-Radmoghaddam Z; Gharaghani S; Mohammadi-Khanaposhtanai M
    Mol Divers; 2021 Aug; 25(3):1811-1825. PubMed ID: 33565001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.
    Recanatini M; Cavalli A; Belluti F; Piazzi L; Rampa A; Bisi A; Gobbi S; Valenti P; Andrisano V; Bartolini M; Cavrini V
    J Med Chem; 2000 May; 43(10):2007-18. PubMed ID: 10821713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease.
    Dhamodharan G; Mohan CG
    Mol Divers; 2022 Jun; 26(3):1501-1517. PubMed ID: 34327619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 3D-QSAR study of 110 diverse, dual binding, acetylcholinesterase inhibitors based on alignment independent descriptors (GRIND-2). The effects of conformation on predictive power and interpretability of the models.
    Vitorović-Todorović MD; Cvijetić IN; Juranić IO; Drakulić BJ
    J Mol Graph Model; 2012 Sep; 38():194-210. PubMed ID: 23073222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
    Kumar V; De P; Ojha PK; Saha A; Roy K
    Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
    Fatemi MH; Heidari A; Gharaghani S
    J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE).
    Araújo JQ; de Brito MA; Hoelz LV; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
    Eur J Med Chem; 2011 Jan; 46(1):39-51. PubMed ID: 21074294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
    El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M
    J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico approaches to evaluate the molecular properties of organophosphate compounds to inhibit acetylcholinesterase activity in housefly.
    Marimuthu P; Lee YJ; Kim B; Seo SS
    J Biomol Struct Dyn; 2019 Feb; 37(2):307-320. PubMed ID: 29322868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
    Roy KK; Dixit A; Saxena AK
    J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
    Zhang S; Hou B; Yang H; Zuo Z
    Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D QSAR based Virtual Screening of Flavonoids as Acetylcholinesterase Inhibitors.
    Andole S; Sd H; Sudhula S; Vislavath L; Boyina HK; Gangarapu K; Bakshi V; Devarakonda KP
    Adv Exp Med Biol; 2023; 1424():233-240. PubMed ID: 37486499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors.
    Abuhamdah S; Habash M; Taha MO
    J Comput Aided Mol Des; 2013 Dec; 27(12):1075-92. PubMed ID: 24338032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GA strategy for variable selection in QSAR studies: application of GA-based region selection to a 3D-QSAR study of acetylcholinesterase inhibitors.
    Hasegawa K; Kimura T; Funatsu K
    J Chem Inf Comput Sci; 1999; 39(1):112-20. PubMed ID: 10094610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors.
    Zhong W; Liu P; Zhang Q; Li D; Lin J
    J Biomol Struct Dyn; 2017 Oct; 35(13):2853-2867. PubMed ID: 27809674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
    Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
    SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docking and QSAR analysis of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Asadollahi-Baboli M; Dehnavi S
    Comput Biol Chem; 2018 Oct; 76():283-292. PubMed ID: 30103106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative structure-activity relationship of organophosphate compounds based on molecular interaction fields descriptors.
    Zhao J; Yu S
    Environ Toxicol Pharmacol; 2013 Mar; 35(2):228-34. PubMed ID: 23348103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A combinatorial feature selection approach to describe the QSAR of dual site inhibitors of acetylcholinesterase.
    Asadabadi EB; Abdolmaleki P; Barkooie SM; Jahandideh S; Rezaei MA
    Comput Biol Med; 2009 Dec; 39(12):1089-95. PubMed ID: 19854437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors.
    Ul-Haq Z; Mahmood U; Jehangir B
    Chem Biol Drug Des; 2009 Dec; 74(6):571-81. PubMed ID: 19843075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.